Risedronic acid – March 2023

• Brand names:
  • Actonel® EC
• Pharmaceutical Company:
  • Theramex Australia Pty Ltd
• Condition/Indication: Osteoporosis
• Meeting Date: March 2023
• Public Summary Document (PSD) November 2022 March 2023 PBAC Meetings - (PDF 705KB)
• Public Summary Document (PSD) November 2022 March 2023 PBAC Meetings - (Word 158KB)

Related Public Summary Documents

• Risedronic acid – November 2022